JP2010504285A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504285A5
JP2010504285A5 JP2009526743A JP2009526743A JP2010504285A5 JP 2010504285 A5 JP2010504285 A5 JP 2010504285A5 JP 2009526743 A JP2009526743 A JP 2009526743A JP 2009526743 A JP2009526743 A JP 2009526743A JP 2010504285 A5 JP2010504285 A5 JP 2010504285A5
Authority
JP
Japan
Prior art keywords
substituted
group
independently represents
residue
following formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2009526743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/019201 external-priority patent/WO2008027551A2/en
Publication of JP2010504285A publication Critical patent/JP2010504285A/ja
Publication of JP2010504285A5 publication Critical patent/JP2010504285A5/ja
Abandoned legal-status Critical Current

Links

JP2009526743A 2006-09-01 2007-08-31 デンドリマー組成物 Abandoned JP2010504285A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84156606P 2006-09-01 2006-09-01
US84943406P 2006-10-05 2006-10-05
US85344006P 2006-10-23 2006-10-23
PCT/US2007/019201 WO2008027551A2 (en) 2006-09-01 2007-08-31 Dendrimer compositions

Publications (2)

Publication Number Publication Date
JP2010504285A JP2010504285A (ja) 2010-02-12
JP2010504285A5 true JP2010504285A5 (cg-RX-API-DMAC7.html) 2010-10-14

Family

ID=39136625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009526743A Abandoned JP2010504285A (ja) 2006-09-01 2007-08-31 デンドリマー組成物

Country Status (5)

Country Link
US (2) US20100234309A1 (cg-RX-API-DMAC7.html)
EP (1) EP2068819A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010504285A (cg-RX-API-DMAC7.html)
BR (1) BRPI0716066A2 (cg-RX-API-DMAC7.html)
WO (1) WO2008027551A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5093680B2 (ja) * 2008-06-26 2012-12-12 独立行政法人産業技術総合研究所 ビス四級アンモニウム塩コア型デンドリマー
MX348821B (es) 2010-02-24 2017-06-30 Relypsa Inc Polímeros de amina para usarse como secuestrantes del ácido biliar.
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR20240152425A (ko) * 2013-06-05 2024-10-21 트리시다, 인크. 경구 투여를 위한 양성자-결합 중합체
EP3718551A1 (en) 2014-12-10 2020-10-07 Tricida Inc. Proton-binding polymers for oral administration
CN116211887A (zh) 2016-05-06 2023-06-06 特里赛达公司 用于治疗酸碱失衡的组合物
IL273960B2 (en) 2017-11-03 2025-08-01 Tricida Inc Nonabsorable compositions for use in treating or preventing metabolic acidosis
CN109437415B (zh) * 2018-10-12 2021-09-28 山东理工大学 无磷反渗透阻垢剂per-pamam及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US20030180250A1 (en) * 2002-03-22 2003-09-25 Council Of Scientific And Industrial Research Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents

Similar Documents

Publication Publication Date Title
JP2010504285A5 (cg-RX-API-DMAC7.html)
ES2581728T3 (es) Derivados de C-aril-glucósido, procedimiento de preparación y uso farmacéutico de los mismos
JP2021042235A5 (cg-RX-API-DMAC7.html)
JP2022000444A5 (cg-RX-API-DMAC7.html)
RU2010152758A (ru) Кристаллическая форма и тозилат соединения тетрациклина, кристаллическая форма указанного тозилата и ее полиморфная модификация, способ получения тозилата соединения тетрациклина, полиморфная модификация, полученная указанным способом, и фармацевтические композиции на основе вышеуказанных кристаллической формы и полиморфной модификации
MX2010009854A (es) Agente para liberacion de sustancia funcional.
EP2031007A3 (en) Norbornene-type polymers, compositions thereof and lithographic processes using such compositions
AR074359A1 (es) Compuestos heterociclicos sustituidos como moduladores de canales ionicos
EP1832617A3 (en) Polyfunctional phenylene ether oligomer, derivative thereof, resin composition containing the same, and use thereof
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2010504975A5 (cg-RX-API-DMAC7.html)
RU2012122367A (ru) Способ получения простагландинов и промежуточные соединения для их получения
JP2010511036A5 (cg-RX-API-DMAC7.html)
JP2005536503A5 (cg-RX-API-DMAC7.html)
WO2008008481A3 (en) Deprotection of functional groups by multi-photon induced electron transfer
RU2016133471A (ru) Композиции и способы для лечения диабета и заболеваний печени
AR108558A2 (es) Método para preparar ácido (+)-1,4-dihidro-7-[(3s,4s)-3-metoxi-4-(metilamino)-1-pirrolidinil]-4-oxo-1-(2-tiazolil)-1,8-naftiridin-3-carboxílico
JP2018523643A5 (cg-RX-API-DMAC7.html)
JP6211746B1 (ja) 樹脂組成物
JP2012532894A5 (cg-RX-API-DMAC7.html)
JPWO2021187531A5 (cg-RX-API-DMAC7.html)
JPS5857361A (ja) 新規の2−(ヒドロキシ−フェニル)−インド−ル、その製造法及び該化合物を含有する抗腫瘍剤
CN106748676B (zh) 一种去除1,1,2,3,3,3-六氟丙基氢氟醚粗品中不饱和杂质的方法
JP2008540628A5 (cg-RX-API-DMAC7.html)
RU2011148101A (ru) Новые кристаллы сольватов